Susan G. Hilsenbeck

Also affiliated with Breast Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

6.5Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 46 papers — median percentile 82. Top paper: “Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment”.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2566

N/A

1.3DataRank · unranked

43 citations

Hee-Jin Jang, Maheshwari Ramineni, Daniel Wang, Daniela Ramos, Jong Min Choi +10 more

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00079-2

N/A

1.3DataRank · unranked

67 citations

Eric K. Rowinsky, Brandon G. Smaglo, Wasif M. Abidi, Mohamed O. Othman, Kalpesh Patel +15 more

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Journal of Clinical Oncology(2008)10.1200/jco.2007.13.4429

N/A

0.834DataRank · unranked

259 citations

Angelo Casa, ZaWaunyka Lazard, Shixia Huang, Anna Tsimelzon, Susan G. Hilsenbeck +5 more

A comprehensive atlas of AAV tropism in the mouse

Molecular Therapy(2025)10.1016/j.ymthe.2025.01.041

Top 27%

0.752DataRank

Top 27%39 citations

Kathy J. Snow, Jote Bulcha, Aaron R. Cox, Alexa Martinez, M. Cecilia Ljungberg +21 more

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

UNC Libraries(2020)10.17615/43yk-w772

Top 31%

0.649DataRank

Top 31%17 citations

Qing Lai, Pavel Zuloaga, Amber M. Froehlich, Edward S. Chen, Jian Huang +24 more

Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2961

N/A

0DataRank · unranked

12 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jin-Ah Kim +13 more

Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer

Cancer Prevention Research(2021)10.1158/1940-6207.capr-21-0031

N/A

0DataRank · unranked

14 citations

Wen Bu, Weiyu Jiang, Amy Ku, Jyoti Kapali, Sagar Dhamne +5 more

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1799

N/A

0DataRank · unranked

6 citations

Gary M. Clark, Charles A. Coltman, Mary L. Disis, S. Gail Eckhardt, Lee M. Ellis +21 more

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

npj Breast Cancer(2021)10.1038/s41523-021-00274-0

N/A

0DataRank · unranked

11 citations

Carolina Gutiérrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J. Shea +16 more

Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation

UNC Libraries(2021)10.17615/bxh8-g735

N/A

0DataRank · unranked

3 citations

Yi‐Hua Liao, Xiang Zhang, Chad J. Creighton, Yi Li, Eric L. Chang +12 more

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.20.457116

N/A

0DataRank · unranked

5 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram +19 more

Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.16.448722

N/A

0DataRank · unranked

0 citations

Elena B. Kabotyanski, Elizabeth Villegas, Jonathan H. Shepherd, Deanna Acosta, Clark Hamor +11 more

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

iScience(2022)10.1016/j.isci.2022.105799

N/A

0DataRank · unranked

35 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram Srinivasan +25 more

STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential

Oncogene(2022)10.1038/s41388-022-02500-w

N/A

0DataRank · unranked

9 citations

Amy T. Ku, Jie Dong, Fei Yue, Weiyu Jiang, Ahmed Atef Ibrahim +14 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1

N/A

0DataRank · unranked

2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

Effect of mevalonate pathway inhibitors on outcomes of patients (pts) with HER2-positive early breast cancer (BC) in the ALTTO trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.522

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Lieveke Ameye, Marianne Paesmans, Sarra El-Abed +13 more

Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

Journal of Clinical Investigation(2023)10.1172/jci172503

N/A

0DataRank · unranked

30 citations

Elena B. Kabotyanski, Alexander B. Saltzman, Anna Malovannaya, Xueying Yuan, Lucas C. Reineke +16 more

Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer

npj Breast Cancer(2023)10.1038/s41523-022-00502-1

N/A

0DataRank · unranked

23 citations

Shirong Cai, Yizheng Tu, Jiansu Shao, Emily Powell, Abena B. Redwood +22 more

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0044

N/A

0DataRank · unranked

8 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer: Experience from a safety-net hospital serving a racially and ethnically diverse patient population.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.150

N/A

0DataRank · unranked

3 citations

Heidi Dowst, Neda Zarrin‐Khameh, Quillan Huang, Attiya Batool Noor, Guilherme Godoy +6 more

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.28.559973

N/A

0DataRank · unranked

3 citations

Elena B. Kabotyanski, Alexander B. Saltzman, Anna Malovannaya, Xueying Yuan, Lucas C. Reineke +16 more

Data from Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

(2023)10.1158/0008-5472.c.6500892

N/A

0DataRank · unranked

0 citations

Runsheng Wang, Jiangyong Miao, Esther Oliva, Xiaoyun Shen, Thomas M. Wheeler +4 more

Data from Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

(2023)10.1158/0008-5472.c.6500892.v1

N/A

0DataRank · unranked

0 citations

Runsheng Wang, Jiangyong Miao, Esther Oliva, Xiaoyun Shen, Thomas M. Wheeler +4 more

Data from Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

(2023)10.1158/1078-0432.c.6531045

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jinah Kim +13 more

Data from A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis

(2023)10.1158/0008-5472.c.6513421.v1

N/A

0DataRank · unranked

0 citations

Weiyu Jiang, Amy T. Ku, Adelaide I.J. Young, Weijie Zhang, Eric P. Souto +15 more

Data from Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast Cancer

(2023)10.1158/0008-5472.c.6500456

N/A

0DataRank · unranked

0 citations

Jason I. Herschkowitz, Kathryn L. Schwertfeger, Bryan E. Welm, Yiqun Zhang, Brian York +7 more

Data from Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer

(2023)10.1158/1078-0432.c.6516967

N/A

0DataRank · unranked

0 citations

Anna Tsimelzon, K. Sexton, Ashley M. Herrick, Carolina Gutiérrez, Aedín C. Culhane +5 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer

(2023)10.1158/1078-0432.c.6516967.v1

N/A

0DataRank · unranked

0 citations

Anna Tsimelzon, K. Sexton, Ashley M. Herrick, Carolina Gutiérrez, Aedín C. Culhane +5 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603.v1

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer

(2023)10.1158/1940-6207.c.6547696.v1

N/A

0DataRank · unranked

0 citations

Wen Bu, Weiyu Jiang, Amy T. Ku, Jyoti Kapali, Sagar Dhamne +5 more

Data from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

(2023)10.1158/2767-9764.c.6729507.v2

N/A

0DataRank · unranked

0 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast Cancer Research(2024)10.1186/s13058-024-01778-w

N/A

0DataRank · unranked

16 citations

Yanxia Ma, William M. Tahaney, Cassandra L. Moyer, Amanda Lanier, Jamal Hill +8 more

ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps632

N/A

0DataRank · unranked

2 citations

Kathryn J. Ruddy, Naim U. Rashid, Jasmine Sukumar, Sharon H. Giordano, Gaorav P. Gupta +10 more

Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer

Cancer Discovery(2025)10.1158/2159-8290.cd-23-1173

N/A

0DataRank · unranked

3 citations

Shankha Satpathy, Karsten Krug, Jitendra K. Meena, Nivetha Ramesh Babu, Cheyenne Calderon +51 more

Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0873

N/A

0DataRank · unranked

3 citations

Cristian G. Medina, Deborah R. Surman, Lacey E. Dobrolecki, Monica Vilchis, Maheshwari Ramineni +10 more

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

UNC Libraries(2025)10.17615/se9n-4867

N/A

0DataRank · unranked

0 citations

Cheng Fan, Elena B. Kabotyanski, Alexander B. Saltzman, Kazem Safari, Diego A. Pedroza +16 more

Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.02.003

N/A

0DataRank · unranked

107 citations

Meenakshi Anurag, Jonathan T. Lei, Jin Cao, Purba Singh, Jianheng Peng +26 more

BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression

npj Breast Cancer(2020)10.1038/s41523-020-0157-z

N/A

0DataRank · unranked

19 citations

Yan Hong, Darlene Limback, Ruonan Zhao, Jenna Berger, Stephanie Bishop +22 more

Intratumoral Heterogeneity in a Trp53-Null Mouse Model of Human Breast Cancer

UNC Libraries(2020)10.17615/vgd4-dp70

N/A

0DataRank · unranked

4 citations

Susan G. Hilsenbeck, Chi Hsuan Chang, Charles M. Perou, Jeffrey M. Rosen, Cheng Fan +3 more

Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus-Wnt-1 Mouse Model of Breast Cancer

UNC Libraries(2020)10.17615/mp1b-n734

N/A

0DataRank · unranked

0 citations

Charles M. Perou, Jeffrey M. Rosen, Brian York, Susan G. Hilsenbeck, Chad J. Creighton +7 more

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4191

N/A

0DataRank · unranked

94 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis

Cancer Research(2021)10.1158/0008-5472.can-21-1112

N/A

0DataRank · unranked

32 citations

Weiyu Jiang, Amy T. Ku, Adelaide I.J. Young, Weijie Zhang, Eric P. Souto +15 more

Susan G. Hilsenbeck

Indexed papers

Top data-sharing exemplar

Papers